Trials / Completed
CompletedNCT01422824
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis
An Observational. Non-interventional Study to Observe the Safety and Efficacy of MIRCERA in the Treatment of Chronic Renal Anemia in Maintenance ESA Treated Patients on Haemodialysis (STABILE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 185 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective observational study will evaluate the safety and efficacy of Mircera (methoxy polyethylene glycol-epoetin beta) in patients with chronic renal anemia on haemodialysis in maintenance ESA treatment. Data will be collected from patients receiving once monthly Mircera according to standard of care and local labelling during 12 months of treatment.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2011-08-24
- Last updated
- 2016-03-28
- Results posted
- 2016-03-28
Locations
6 sites across 1 country: North Macedonia
Source: ClinicalTrials.gov record NCT01422824. Inclusion in this directory is not an endorsement.